In the News

$100 Million Dollar Verdict Spurs Settlement Talks in Vaginal Mesh Cases

Johnson & Johnson Hit with $2.5 Million Verdict

Johnson & Johnson fails to warn that its antipsychotic drug Risperdal could cause male breast growth.

Johnson & Johnson Loses Risperdal Trial

A Philadelphia jury said Johnson & Johnson should pay $2.5 million.

Johnson & Johnson Loses Trial Over Risperdal

Philadelphia jury decided Johnson & Johnson must pay $2.5 million in damages for failing to warn that Risperdal antipsychotic could cause gynecomastia.

Pa. State Court Creates Xarelto Blood Thinner Mass Tort in Philadelphia

A Pennsylvania state court has created a mass tort docket for Xarelto blood thinner injury cases filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals.

Xarelto Mass Tort Case Established in Philadelphia

Litigation surrounding Xarelto, a blood thinner that is alleged by plaintiffs to cause uncontrollable and sometimes fatal bleeding, has been organized into a mass tort in Philadelphia.

Depuy Orthopaedics, Inc – LPS Lower Extremity Dovetail Intercalary Component

First Round of Depuy ASR Settlement Payments to Begin

Health Insurers to Stop Covering Uterine Procedure Where Surgical Tool Can Spread Cancer

Johnson & Johnson Pulls Hysterectomy Device From Hospitals